About
Royalmount Biopharma Services
Our Progression
Our parent company Pharmascience Inc. has developed strong roots in Canada, and is Quebec’s largest employer in the pharmaceutical field with over 1600 employees.
Royalmount CDMO has been operating out of the Candiac facility since 2014,
maintaining operations at this FDA-approved site. The facility’s capabilities have increased over time, progressing from development and manufacturing of small molecules to incorporating large molecules as well, such as Oligonucleotides, Monoclonal antibodies (mAbs) and Antibody-drug conjugates (ADCs).
Royalmount Labs external CRO business has become very successful, excelling in scientific excellence, customer service and on-time delivery. To accommodate the rapid growth, we continue to invest in the right staff, in the expansion and modernization of our laboratories, as well as in the latest technologies.
Where We Are Now
Pharmascience Inc. is currently Canada’s third largest generic pharmaceutical company.
Royalmount CDMO provides an extensive suite of services supporting drug
development from pre-clinical phases through to commercial supply. As one of the few FDA-approved facilities in North America with cytotoxic capabilities, our team is equipped to deliver solutions for vials, pre-filled syringes, and lyophilized products.
Royalmount Labs now employs over 60 scientific, technical and support staff, and occupies 10000 sq ft of purpose built laboratory and office space. We have the latest state-of-the-art instrumentation including LC-MS/MSs, MSD, multimode spectrophotometer plate readers, Luminex, qPCR, and robotic liquid handling systems.
As a partner of choice for many pharma, biotech and virtual companies, Royalmount Biopharma Services have a very high rate of repeat business, and this is a testament to our three core principles that we consistently deliver on to our clientele – Scientific Excellence; Customer Service; On-time Delivery.
Where We’re Going
Royalmount CDMO is completing an expansion that will triple its production capacity, enabling increased manufacturing of Vials, Pre-filled Syringes, and Lyophilized products for third-party clients. The CDMO continues to advance its capabilities with isolator vial line, automated visual inspection and integrated label, packaging, and cartoning technologies. Furthermore, the CMDO group consistently seeks to incorporate state-of-the-art equipment to further enhance its services and product offerings.
Royalmount Labs has ambitious growth plans for the next several years, including introducing new service offerings. We aim to become the leading niche small and large molecule bioanalytical CRO.
Quality, always on time
Study-based inspections (study plan, in-process, study data and report for every study and validation); additionally perform regular facility-based and process-based inspections.
Strict adherence to Health Canada, EMA, and US FDA guidelines, ensuring the highest-quality procedures, data and reports.
Quality Assurance / Compliance Internal Auditors functions as an independent Quality Assurance Unit.
Quality Control / Data Review Team reviews 100% of raw data generated in the bioanalytical laboratories.
- FDA audits in 2018 (onsite) and 2022 (virtual); no FDA 483 issued
- GLP certified by Standards Council of Canada (SCC) since 2015; most recent re-certification in 2025
- GCP inspected by Health Canada in 2018 and 2024
- GMP inspected by Health Canada in 2020, 2022 and 2024
Bioanalytical Labs Customer Commitments
Regulatory Agencies
OUR FACILITIES
Our Montreal based GLP/GMP/GCP-compliant laboratories act as a key partner for numerous pharmaceutical and biotechnology companies. We adapt to the rapidly changing needs of our clients, overcoming the challenges related to regulated bioanalysis.
- Over 60 dedicated professionals
- 12 triple quadrupole mass specs including API 6500+ and 5000™
- 250,000 bioanalytical samples analyzed per year
- >500 validated assays available; extensive method development capabilities
- 2 Shimadzu ICP-MS
- 1 Meso Sector S 600MM (MSD)
- 1 QuantStudio 7 qPCR
- 2 Agilent microplate spectrophotometer readers
- 1 Luminex
- 2 Hamilton® STAR™
Our CDMO facility is strategically situated just 30 minutes from the US border. The site’s agility enables us to collaborate effectively with clients to address their project requirements for vials, pre-filled syringes, and lyophilized products.
- Franz Ziel Isolator
- Bausch and Strobel Filler
- GEA Lyophilizer
- Automated visual inspection for Vial and PFS Formats
- Automated label, packaging and cartoning technologies
Our team
With over 25 years of experience leading international companies in the pharmaceutical and automotive sectors, Gabriel has held strategic leadership roles within major organizations, including Fortune 500 companies, family-owned businesses, and private equity-backed firms. He has led teams at Aptar Pharma, Becton Dickinson, and PPG Industries, where he oversaw major organizational transformations, acquisition projects, and strategic industrial launches.
Peter has over 15 years of experience in the Pharmaceutical industry. His experience spans from preclinical and clinical development, bioanalytical sales, API sales, to Generic injectable manufacturing. He received his undergraduate degree from The University of California Irvine in Biology, and a Masters Degree in Biotechnology from The University of Pennsylvania (UPENN).
Adrien has over 25 years of experience in the management of analytical and bioanalytical laboratory operations. Having joined Pharmascience in 2010, Adrien has executive responsibilities for Royalmount Laboratories. Adrien has a Doctor of Science degree in chemistry from the University of Antwerp in Belgium.
With over 25 years’ regulated bioanalysis experience spanning from preclinical and clinical CROs to pharmaceutical companies, John, who led the bioanalytical laboratory operations at Pharmascience for 8 years, is now responsible for business development.
Renée has over 25 years of expertise in preclinical and clinical bioanalysis of large molecules, immunogenicity, and biomarkers within the CRO sector. Prior to joining Pharmascience Royalmount Labs, Renee was with Charles River Labs / Citoxlab for 12 years in scientific positions of increasing responsibility, ultimately as Director, Immunology. She was also with Theratechnologies for 7 years and MDS Pharma Services for 2 years. She holds a master’s degree in microbiology and immunology from the University of Montreal, and a Project Management certificate from HEC Montreal.
With over 15 years of experience in leading multinational companies in biotechnology and agri-food, Caroline has developed deep expertise in business development and the implementation of growth strategies. She holds a degree in microbiology from the University of Montreal, an MBA from Laval University, a certification in integrating sustainable development into business from the University of Cambridge (UK), and a certification in B2B marketing strategy from Columbia University (USA).
Elia is a seasoned leader with over 10 years of pharmaceutical industry experience, specializing in client-facing CDMO operations and injectables. Since joining Pharmascience in 2016, he has held progressive leadership roles and currently oversees CDMO operations within Royalmount Biopharma Services. In this role, Elia ensures seamless coordination across internal functions to deliver on client commitments and optimize operational processes. He holds both a Master’s and PhD in Neuroscience from McGill University.
Franco brings over 15 years of experience in medical devices, strategic projects, and analytics. He spent almost ten years at Pharmascience, where he led efforts in project management, analytics, and business development. Franco is recognised for his ability to blend creative and analytical thinking, excellent communication, and strong relationship-building skills. His leadership style is collaborative, and he excels at handling complex situations. He holds an MBA in Global Leadership and Strategy from McGill University and Nanyang Technological University and is driven by a passion for helping organizations evolve through complex challenges.
Aleksandra Isakovic is the Marketing and Business Development Manager at Royalmount Biopharma Services, where she leverages her deep understanding of the life sciences landscape to drive strategic partnerships and client engagement across the pharma and biotech sectors. With extensive experience and a strong commitment to fostering relationships that move science forward, she is dedicated to advancing innovative laboratory solutions that support discovery through commercialization.
Cristina has developed a strong financial background through diverse roles at Pharmascience over the past several years. She holds a Master’s degree in Management Control and is a Certified Public Accountant (CPA).
Our lab team
Weixing is an experienced scientist and leader of the bioanalytical method development team. With a master’s degree and PhD in chromatographic separation science and mass spectrometry, Weixing has been responsible for the development of over 400 quantitative mass spectrometry-based methods for the measurement of small molecules, metabolites and proteins in complex biological matrices.
Hong, who has extensive PK/TK reporting experience, has held positions as Senior PK/PD Scientist at Algorithme Pharma, and Charles River Laboratories, as well as Scientific/Technology Consultant for several investment firms. Prior to this, Hong was PK Scientist for Pharmanet Development Group (Syneos) and Senior Research Associate for the Cancer Therapy & Research Centre. Hong received his undergraduate training in Biochemistry, completed an MSc in Physiology, and received an MBA from the University of Laval.
Ying, who joined Pharmascience in 2016, is currently responsible for Nitrosamine impurities analysis by LC-MS/MS, and elemental testing by ICP-MS. Ying has over 20 years’ of experience working in the chemistry field under GLP and GMP regulated environments. Ying has a MSc degree in chemistry, and she is also a Registered Quality Assurance Professional in Good Laboratory Practice (RQAP-GLP).
With over 24 years of experience in regulated bioanalysis and CRO industry, Giuseppina has overall responsibility for QC and QA functions that assure GLP/ GCP/ GMP compliance. Giuseppina has a bachelor’s degree from Concordia University in science (specialization in chemistry).
With over 30 years of experience in bioanalysis, including 25 years in CRO preclinical and clinical bioanalysis, Samantha oversees the LC-MS/MS Bioanalytical Operations. Samantha has a bachelor’s degree with honors in Pharmaceutical Sciences.